质母细胞瘤患者的预后随着时间的推移显著改善,询问历史对照
A Thomas-Joulié1, S Tran2, L El Houari3
1Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie-Oncologie, F-75013 Paris, France; AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service d'Oncologie-Radiothérapie, F-75013 Paris, France.
概括
随着时间的推移,质母细胞瘤的存活率正在改善,最近的患者与早期队列相比,平均整体存活率 (mOS) 显著增加. 这表明,支持性护理和治疗优化的进步可以提高脑癌患者的治疗结果.
科学领域:
- 神经瘤学神经瘤学
- 临床研究是临床研究.
- 癌症存活率分析
背景情况:
- 质母细胞瘤 (GBM) 是成年人的一种高度攻击性的原发性脑瘤.
- 临床观察表明,随着时间的推移,GBM患者的平均整体存活率 (mOS) 正在增加.
研究的目的:
- 以回顾性分析GBM患者的预后,并验证观察到的mOS的增加.
- 确定有助于改善GBM患者生存的因素.
主要方法:
- 对722名新诊断的GBM患者 (年龄<70岁,卡诺夫斯基性能状态>70%) 的回顾性分析.
- 患者根据诊断年份 (2005-2012年 vs. 2013-2018年) 分为两组.
- 使用单变量和多变量考克斯回归分析的组之间的mOS的比较.
主要成果:
- 患者和瘤的特征在各组之间是相似的,控制混因素.
- 最近诊断组 (2013-2018) 与早期组 (19个月) 相比,显示了显著更长的mOS (未达到).
- 诊断时间是改善mOS的显著预后因素 (aHR0.49,p < 0.001).
结论:
- 在GBM患者中观察到的mOS的增加具有统计学意义.
- 改善的患者管理,优化的护理标准和临床试验参与可能解释了增强的生存率.
- 对支持性护理和治疗副作用管理的进一步研究是有必要的.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


